市場調査レポート

商品コード

1747286

前臨床CRO市場、サービス別、タイプ別、動物モデル別、モデルシステム別、用途別、エンドユーザー別、地域別

Preclinical CRO Market, By Service, By Type, By Animal Model, By Model System, By Application, By End Users, By Geography

出版日: 2025年05月05日
発行: Coherent Market Insights
ページ情報: 英文 168 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 657,360円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,022,560円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,460,800円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

前臨床CROの世界市場規模は2025年に67億6,000万米ドルと推定され、2032年には122億1,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR8.82％で成長すると予測されます。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	67億6,000万米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年 CAGR：	8.82%	2032年の価値予測	122億1,000万米ドル

世界の前臨床CRO市場は、製薬企業やバイオテクノロジー企業による前臨床研究活動のアウトソーシング需要の高まりに牽引され、近年大きな成長を遂げています。前臨床試験受託機関（CRO）は、毒性試験、薬物動態・薬力学試験、動物モデル開発など幅広いサービスを提供し、創薬・研究開発プロセスにおいて重要な役割を果たしています。これらの組織は、医薬品開発の前臨床段階を合理化することで、製薬会社がコアコンピタンスに集中し、新治療法の市場開拓を加速することを可能にしています。前臨床CRO市場は競争が激しく、複数の主要企業が世界に事業を展開し、顧客の進化するニーズに対応するため、専門的なサービスと高度な技術を提供しています。製薬業界が研究開発コストの上昇や規制当局の監視強化といった課題に直面し続ける中、前臨床CROサービスの需要は今後数年でさらに拡大すると予想されます。

市場力学：

世界の前臨床CRO市場は、製薬企業やバイオテクノロジー企業による前臨床研究活動のアウトソーシングの増加、専門的な前臨床サービスに対する需要の高まり、医薬品開発コストとスケジュール短縮の必要性など、いくつかの要因によって牽引されています。前臨床試験をCROに委託することで、企業は多額の設備投資をすることなく、専門的な知識、高度な技術、最先端の施設を利用することができます。さらに、医薬品開発の複雑化に加え、厳格な規制要件に準拠する必要性が、前臨床CROサービスに対する需要をさらに高めています。しかし、前臨床試験のコストが高いこと、熟練した専門家が限られていること、データセキュリティや知的財産保護に関連する課題があることなどの要因により、市場の成長が抑制される可能性があります。このような課題にもかかわらず、前臨床CRO市場は、3D細胞培養、臓器オンチップ、インシリコモデリングなど、前臨床試験の予測性と効率性の向上に役立つ先進技術の採用増加により、大きな成長機会を示しています。さらに、個別化医療への需要の高まりや、希少疾患や希少疾病用医薬品への注目の高まりは、今後数年間で、前臨床CROに新たなビジネスチャンスをもたらすと予想されます。

本調査の主な特徴

本レポートでは、世界の前臨床CRO市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模およびCAGRを掲載しています。
また、さまざまなセグメントにおける潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の前臨床CRO市場の主要企業をプロファイルしています。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関して、情報に基づいた意思決定を行うことができます。
前臨床CROの世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。
利害関係者は、世界の前臨床CRO市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 6.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.82%	2032 Value Projection:	USD 12.21 Bn

The global preclinical CRO market has witnessed significant growth in recent years, driven by the increasing demand for outsourcing preclinical research activities by pharmaceutical and biotechnology companies. Preclinical Contract Research Organizations (CROs) play a crucial role in the drug discovery and development process, providing a wide range of services such as toxicology testing, pharmacokinetic and pharmacodynamic studies, and animal model development. These organizations help streamline the preclinical phase of drug development, enabling pharmaceutical companies to focus on their core competencies and accelerate the delivery of new therapies to the market. The preclinical CRO market is highly competitive, with several key players operating globally, offering specialized services and advanced technologies to meet the evolving needs of their clients. As the pharmaceutical industry continues to face challenges such as rising research and development costs and increasing regulatory scrutiny, the demand for preclinical CRO services is expected to grow further in the coming years.

Market Dynamics:

The global preclinical CRO market is driven by several factors, including the increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies, the growing demand for specialized preclinical services, and the need to reduce drug development costs and timelines. Outsourcing preclinical studies to CROs allows companies to access specialized expertise, advanced technologies, and state-of-the-art facilities, without the need for significant capital investments. Additionally, the increasing complexity of drug development, coupled with the need to comply with stringent regulatory requirements, has further fueled the demand for preclinical CRO services. However, the market growth may be restrained by factors such as the high cost of preclinical studies, the limited availability of skilled professionals, and the challenges associated with data security and intellectual property protection. Despite these challenges, the preclinical CRO market presents significant opportunities for growth, driven by the increasing adoption of advanced technologies such as 3D cell culture, organ-on-a-chip, and in silico modeling, which can help improve the predictivity and efficiency of preclinical studies. Moreover, the growing demand for personalized medicine and the increasing focus on rare diseases and orphan drugs are expected to create new opportunities for preclinical CROs in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global preclinical CRO market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global preclinical CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Charles River Laboratories, Covance (Labcorp), WuXi AppTec, ICON plc, PPD (Part of Thermo Fisher Scientific), Medpace, Evotec SE, Syneos Health, BioReliance (Merck KGaA), Charles River, KCR, Parexel International, Inotiv, Toxikon, and Harlan Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global preclinical CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical CRO market

Market Segmentation

Service Insights (Revenue, USD Bn, 2020 - 2032)
- Bioanalysis and DMPK studies
- In vitro ADME
- In-vivo PK
- Toxicology Testing
- GLP
- Non-GLP
- Compound Management
- Process R&D
- Custom Synthesis
- Others
- Chemistry
- Medicinal Chemistry
- Computation Chemistry
- Safety Pharmacology
- Others
Type Insights (Revenue, USD Bn, 2020 - 2032)
- Patient-Derived Organoid (PDO) Models
- Patient-Derived Xenograft (PDX) Models
Animal Model Insights (Revenue, USD Bn, 2020 - 2032)
- Small Animal Model
- Large Animal Model
Model System Insights (Revenue, USD Bn, 2020 - 2032)
- In Vivo
- In Vitro
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Metabolic Disorders
- Others
End Users Insights (Revenue, USD Bn, 2020 - 2032)
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
- Research Institutes and Universities
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Charles River Laboratories
- Covance (Labcorp)
- WuXi AppTec
- ICON plc
- PPD (Part of Thermo Fisher Scientific)
- Medpace
- Evotec SE
- Syneos Health
- BioReliance (Merck KGaA)
- Charles River
- KCR
- Parexel International
- Inotiv
- Toxikon
- Harlan Laboratories

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Preclinical CRO Market, By Service
- Global Preclinical CRO Market, By Type
- Global Preclinical CRO Market, By Animal Model
- Global Preclinical CRO Market, By Model System
- Global Preclinical CRO Market, By Application
- Global Preclinical CRO Market, By End Users
- Global Preclinical CRO Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Preclinical CRO Market, By Service, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Bioanalysis and DMPK studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - In vitro ADME
  - In-vivo PK
Toxicology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - GLP
  - Non-GLP
Compound Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Process R&D
  - Custom Synthesis
  - Others
Chemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Medicinal Chemistry
  - Computation Chemistry
Safety Pharmacology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Preclinical CRO Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Patient-Derived Organoid (PDO) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Patient-Derived Xenograft (PDX) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Preclinical CRO Market, By Animal Model, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Small Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Large Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Preclinical CRO Market, By Model System, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
In Vivo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
In Vitro
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Preclinical CRO Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Preclinical CRO Market, By End Users, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Government and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Institutes and Universities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Preclinical CRO Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Covance (Labcorp)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ICON plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PPD (Part of Thermo Fisher Scientific)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medpace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evotec SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Syneos Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioReliance (Merck KGaA)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
KCR
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Parexel International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Inotiv
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Toxikon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Harlan Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us

前臨床CRO市場、サービス別、タイプ別、動物モデル別、モデルシステム別、用途別、エンドユーザー別、地域別

Preclinical CRO Market, By Service, By Type, By Animal Model, By Model System, By Application, By End Users, By Geography

市場力学：

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の前臨床CRO市場、サービス別、2020年～2032年

第5章世界の前臨床CRO市場、タイプ別、2020年～2032年

第6章世界の前臨床CRO市場、動物モデル別、2020年～2032年

第7章世界の前臨床CRO市場、モデルシステム別、2020年～2032年

第8章世界の前臨床CRO市場、用途別、2020年～2032年

第9章世界の前臨床CRO市場、エンドユーザー別、2020年～2032年

第10章世界の前臨床CRO市場、地域別、2020年～2032年

第11章競合情勢

第12章アナリストの推奨事項

第13章参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Preclinical CRO Market, By Service, 2020-2032, (USD Bn)

5. Global Preclinical CRO Market, By Type, 2020-2032, (USD Bn)

6. Global Preclinical CRO Market, By Animal Model, 2020-2032, (USD Bn)

7. Global Preclinical CRO Market, By Model System, 2020-2032, (USD Bn)

8. Global Preclinical CRO Market, By Application, 2020-2032, (USD Bn)

9. Global Preclinical CRO Market, By End Users, 2020-2032, (USD Bn)

10. Global Preclinical CRO Market, By Region, 2020 - 2032, Value (USD Bn)

11. Competitive Landscape

12. Analyst Recommendations

13. References and Research Methodology

前臨床CRO市場、サービス別、タイプ別、動物モデル別、モデルシステム別、用途別、エンドユーザー別、地域別

Preclinical CRO Market, By Service, By Type, By Animal Model, By Model System, By Application, By End Users, By Geography

市場力学：

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の前臨床CRO市場、サービス別、2020年～2032年

第5章 世界の前臨床CRO市場、タイプ別、2020年～2032年

第6章 世界の前臨床CRO市場、動物モデル別、2020年～2032年

第7章 世界の前臨床CRO市場、モデルシステム別、2020年～2032年

第8章 世界の前臨床CRO市場、用途別、2020年～2032年

第9章 世界の前臨床CRO市場、エンドユーザー別、2020年～2032年

第10章 世界の前臨床CRO市場、地域別、2020年～2032年

第11章 競合情勢

第12章 アナリストの推奨事項

第13章 参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Preclinical CRO Market, By Service, 2020-2032, (USD Bn)

5. Global Preclinical CRO Market, By Type, 2020-2032, (USD Bn)

6. Global Preclinical CRO Market, By Animal Model, 2020-2032, (USD Bn)

7. Global Preclinical CRO Market, By Model System, 2020-2032, (USD Bn)

8. Global Preclinical CRO Market, By Application, 2020-2032, (USD Bn)

9. Global Preclinical CRO Market, By End Users, 2020-2032, (USD Bn)

10. Global Preclinical CRO Market, By Region, 2020 - 2032, Value (USD Bn)

11. Competitive Landscape

12. Analyst Recommendations

13. References and Research Methodology

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の前臨床CRO市場、サービス別、2020年～2032年

第5章世界の前臨床CRO市場、タイプ別、2020年～2032年

第6章世界の前臨床CRO市場、動物モデル別、2020年～2032年

第7章世界の前臨床CRO市場、モデルシステム別、2020年～2032年

第8章世界の前臨床CRO市場、用途別、2020年～2032年

第9章世界の前臨床CRO市場、エンドユーザー別、2020年～2032年

第10章世界の前臨床CRO市場、地域別、2020年～2032年

第11章競合情勢

第12章アナリストの推奨事項

第13章参考文献と調査手法